Fibromyalgia
Basics
Description
- Chronic, widespread noninflammatory musculoskeletal pain syndrome with multisystem manifestations; although the specific pathophysiology has not been fully elucidated, it is generally thought to be a disorder of altered central pain regulation.
- Synonym(s): FMS; fibrositis, fibromyositis (misnomers)
Epidemiology
Incidence
- Predominant sex: female (70–90%) > male
- Predominant age range: 20 to 65 years
Prevalence
2–5% of adult U.S. population; 8% of primary care patients
Etiology and Pathophysiology
- Current consensus is that fibromyalgia is a primary disorder of central pain processing (central sensitization) with increased sensitivity to multiple classes of painful sensation (nociceptive, nociplastic, and neuropathic)
- Alterations in neuroendocrine, neuromodulation, neurotransmitter, neurotransporter, biochemical, and neuroreceptor function/physiology
- Sleep abnormalities—α-wave intrusion
- Systemic inflammation is not a feature of fibromyalgia, although localized immunologic and inflammatory processes in the CNS may play a role. There may be a distinctive cytokine profile in patients with fibromyalgia.
Genetics
- Genetics
- High familial aggregation
- Inheritance is unknown but likely polygenic.
- Odds ratio may be as high as 8.5 for a first-degree relative of a familial proband.
- Environmental—several triggers have been described:
- Physical trauma or severe illness
- Stressors (e.g., work, family, life events, and physical or sexual abuse)
- Viral and bacterial infections
Risk Factors
- Female gender
- Poor functional status
- Negative/stressful life events
- Low socioeconomic status
General Prevention
No known strategies for prevention
Commonly Associated Conditions
- Often a comorbid condition with other rheumatologic or neurologic disorders
- Psychiatric comorbidities, including depression, anxiety, and posttraumatic stress disorder (PTSD) occur in 2/3 of patients—similar to findings in other chronic pain conditions.
- Obesity is common and associated with increased severity of symptoms.
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Domino, Frank J., et al., editors. "Fibromyalgia." 5-Minute Clinical Consult, 33rd ed., Wolters Kluwer, 2025. Medicine Central, im.unboundmedicine.com/medicine/view/5-Minute-Clinical-Consult/116228/all/Fibromyalgia.
Fibromyalgia. In: Domino FJF, Baldor RAR, Golding JJ, et al, eds. 5-Minute Clinical Consult. Wolters Kluwer; 2025. https://im.unboundmedicine.com/medicine/view/5-Minute-Clinical-Consult/116228/all/Fibromyalgia. Accessed December 27, 2024.
Fibromyalgia. (2025). In Domino, F. J., Baldor, R. A., Golding, J., & Stephens, M. B. (Eds.), 5-Minute Clinical Consult (33rd ed.). Wolters Kluwer. https://im.unboundmedicine.com/medicine/view/5-Minute-Clinical-Consult/116228/all/Fibromyalgia
Fibromyalgia [Internet]. In: Domino FJF, Baldor RAR, Golding JJ, Stephens MBM, editors. 5-Minute Clinical Consult. Wolters Kluwer; 2025. [cited 2024 December 27]. Available from: https://im.unboundmedicine.com/medicine/view/5-Minute-Clinical-Consult/116228/all/Fibromyalgia.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Fibromyalgia
ID - 116228
ED - Domino,Frank J,
ED - Baldor,Robert A,
ED - Golding,Jeremy,
ED - Stephens,Mark B,
BT - 5-Minute Clinical Consult, Updating
UR - https://im.unboundmedicine.com/medicine/view/5-Minute-Clinical-Consult/116228/all/Fibromyalgia
PB - Wolters Kluwer
ET - 33
DB - Medicine Central
DP - Unbound Medicine
ER -